These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 3509921)

  • 1. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
    J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
    Scott DW; O'Garra A; Warren D; Klaus GG
    J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
    Page DM; DeFranco AL
    J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
    Pennell CA; Scott DW
    Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells.
    Sarthou P; Henry-Toulmé N; Cazenave PA
    Eur J Immunol; 1989 Jul; 19(7):1247-52. PubMed ID: 2668012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
    Haggerty HG; Monroe JG
    Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
    Francois DT; Katona IM; June CH; Wahl LM; Feuerstein N; Huang KP; Mond JJ
    J Immunol; 1988 May; 140(10):3338-43. PubMed ID: 3129493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol myristate acetate inhibits increases in membrane fluidity induced by anti-IgM in B cells.
    Mizuguchi J; Utsunomiya N; Nakanishi M; Arata Y
    J Immunol; 1988 Apr; 140(8):2495-9. PubMed ID: 3258610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linkage of Ly-6A/E induces Ca2+ translocation in the absence of phosphatidylinositol turnover and mediates proliferation of normal murine B lymphocytes.
    Snapper CM; Yamada H; Mond JJ; June CH
    J Immunol; 1991 Aug; 147(4):1171-9. PubMed ID: 1907991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of cytosolic calcium is sufficient to induce growth inhibition in a B cell lymphoma.
    Muthukkumar S; Udhayakumar V; Bondada S
    Eur J Immunol; 1993 Oct; 23(10):2419-26. PubMed ID: 7691606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
    Ling M; Livnat D; Pillai PS; Scott DW
    J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies.
    Boyd AW; Schrader JW
    J Immunol; 1981 Jun; 126(6):2466-9. PubMed ID: 6785356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation.
    Monroe JG
    J Immunol; 1988 Mar; 140(5):1454-60. PubMed ID: 3126226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell activation. VII. Independent and synergistic effects of mobilized calcium and diacylglycerol on membrane potential and I-A expression.
    Ransom JT; Cambier JC
    J Immunol; 1986 Jan; 136(1):66-72. PubMed ID: 3079612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective induction of high levels of IgA synthesis in Peyer's patch B cells by protein kinase C-activating phorbol esters.
    Li YS; Dearden-Badet MT; Revillard JP
    J Immunol; 1991 Sep; 147(6):1752-8. PubMed ID: 1909730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C activation blocks anti-IgM-mediated signaling BAL17 B lymphoma cells.
    Mizuguchi J; Ji YY; Nakabayaschi H; Huang KP; Beaven MA; Chused T; Paul WE
    J Immunol; 1987 Aug; 139(4):1054-9. PubMed ID: 3038996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and proliferation signals in mouse B cells. I. A comparison of the capacity of anti-Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1.
    Hawrylowicz CM; Keeler KD; Klaus GG
    Eur J Immunol; 1984 Mar; 14(3):244-50. PubMed ID: 6200334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.
    Monroe JG; Kass MJ
    J Immunol; 1985 Sep; 135(3):1674-82. PubMed ID: 2410499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.